InSilixa Lands $13,000,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    365 San Aleso Avenue Sunnyvale, CA 94085 USA
  • Company Description
    InSilixa is building the next generation of high-performance CMOS biochips for microarray technology, qPCR, and DNA sequencing. We are currently in the stealth mode.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    PointGuard’s new fund will invest in software, networking, and hardware to provide technology convergence solutions to many of today’s markets including Mobile Commerce, Cloud Computing, Greentech, Point-of-Care medical, Education, and applied Data Analytics.
  • M&A Terms
  • Venture Investor

Trending on Xconomy